.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DB03_Medrogestone.Medrogestone .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DB03_Medrogestone.Medrogestone| name: | Medrogestone | |
| ATC code: | G03DB03 | |
| route: | oral | |
| compartments: | 1 | |
| dosage: | 5 | mg |
| volume of distribution: | 4 | L |
| clearance: | 35 | L/h |
| other parameters in model implementation | ||
Medrogestone is a synthetic progestogen, previously used for menopausal hormone therapy and sometimes for gynecological disorders. It is not approved or widely used in modern clinical practice.
No published peer-reviewed pharmacokinetic parameters for medrogestone in humans are available. The following is an estimate for a typical adult female following oral administration based on class effects and similar synthetic progestogens.